Increasing Role of Macrolide Anti-inflammatory Therapy in Secondary Organizing Pneumonia.
1Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH 2Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH.
Arjan S
AS
Flora
Hermann
H
Simo
Ragheb
R
Assaly
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D003453:Cryptococcosis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications*; D008172:Lung Diseases, Fungal / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D018942:Macrolides / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D018942:Macrolides; D011241:Prednisone